Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy

Fig. 3

Echocardiographic analysis demonstrates functional improvements following cell sheet implantation. a Representative M-mode images at 4 weeks post-surgery. b–d In the animals treated with cell sheet implantation, left ventricular fractional shortening (b) was significantly higher and both left ventricular end-diastolic diameter (c) and left ventricular end-systolic diameter (d) were significantly reduced as compared to the untreated group. FS fractional shortening, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter

Back to article page